United States · Series A startup

Who invested in Gilgamesh Pharmaceuticals

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$66Mraised across 2 rounds since 2026, from 4 sources

$6.1MVenture$60MSeries A
Latest round
Series A, $60MMar 2026
Step-upi
9.8×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027
$6.1MVenture$60MSeries A
First round
Venture, $6.1M
Feb 2026
Biggest round
$60M
Series A · Mar 2026

The rounds

  1. Mar 2026
    Series A$60M5 returning

    Source recorded and 1 otherSEC filing: $60M sold, first sale Mar 2026

  2. Feb 2026
    Venture$6.1M5 new

    Source recorded and 1 otherSEC filing: $6.1M sold, first sale Jan 2026

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Y CombinatorAccelerator2rounds
Alumni VenturesVC firm2rounds
GaingelsPrivate equity2rounds
Bossa InvestVC firm2rounds
Pioneer FundPrivate equity2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Gilgamesh Pharmaceuticals

Who invested in Gilgamesh Pharmaceuticals?

Gilgamesh Pharmaceuticals's investors include Y Combinator, Alumni Ventures, Gaingels, Bossa Invest and Pioneer Fund.

How much has Gilgamesh Pharmaceuticals raised?

Gilgamesh Pharmaceuticals has raised $66M across 2 rounds since 2026.

When did Gilgamesh Pharmaceuticals last raise?

Gilgamesh Pharmaceuticals's most recent round was a Series A of $60M in Mar 2026.

What was Gilgamesh Pharmaceuticals's biggest round?

Its most recent round, $60M in Mar 2026, is also its largest on record.

Who backed Gilgamesh Pharmaceuticals first?

Gilgamesh Pharmaceuticals's first round on record, in Feb 2026, was backed by Y Combinator, Alumni Ventures and Gaingels and 2 others.

What stage is Gilgamesh Pharmaceuticals at?

Gilgamesh Pharmaceuticals's latest named round is a Series A, in Mar 2026.

Where is Gilgamesh Pharmaceuticals based?

Gilgamesh Pharmaceuticals is based in the United States.

Companies like Gilgamesh Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.